GE HealthCare and Imricor will collaborate to interface Imricor’s Advantage-MR EP Recorder/Stimulator and Northstar-MR 3D Mapping System with GE HealthCare MRI scanners
Imricor, GE HealthCare enter partnership. (Credit: Michal Jarmoluk from Pixabay)
Imricor Medical Systems, a developer of MRI-compatible medical devices, has signed a Memorandum of Understanding (MOU) with medical technology company GE HealthCare.
Under the terms of the MOU, GE HealthCare and Imricor will collaborate to interface Imricor’s Advantage-MR EP Recorder/Stimulator and Northstar-MR 3D Mapping System with GE HealthCare MRI scanners.
The collaboration will enable real-time MRI-guided cardiac ablation procedures using Imricor’s catheters and other devices to be performed on the GE HealthCare MRI platform.
In addition, it would also expand Imricor’s capabilities to interface with GE HealthCare’s new and currently installed MRI scanners.
GE HealthCare MR clinical solutions and research collaborations general manager Anja Brau said: “Imricor’s innovative technology has the potential to bring significant benefit to a large number of cardiac arrhythmia patients.
“GE HealthCare has a long-standing history of applying MR to therapy guidance and control; we would be pleased to add Imricor’s capabilities to provide our customers with more options to treat their patients.”
Imricor offers Vision-MR Ablation Catheter, which is specifically designed to work under real-time MRI guidance to enable rapid, and safe treatment.
Also, it offers high success rates than conventional procedures using x-ray guided catheters.
The Vision-MR Ablation Catheter is already approved in the European Union (EU) for the treatment of type 1 atrial flutter, and the company intends to seek expanded approval in future.
Imricor has also secured regulatory approval for its Advantage-MR EP Recorder/Stimulator System, and the Vision-MR Dispersive Electrode, in the EU.
The company aims to use sites with GE HealthCare MRI systems for the upcoming Vision-MR Ablation of Atrial FLutter (VISABL-AFL) study in the US, and Vision-MR Ablation of Ventricular Tachycardia (VISABL-VT) trial in Europe.
Imricor CEO and chair Steve Wedan said: “We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and Northstar-MR technology.
“The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients.
“We are grateful to our existing customers who have embraced our real-time iCMR ablation technology, and look forward to making the benefits of this technology even more widely available.”